Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer.
Pavarini M, Alborghetti L, Aimonetto S, Maggio A, Landoni V, Ferrari P, Bianculli A, Petrucci E, Cicchetti A, Farina B, Ubeira-Gabellini MG, Salmoiraghi P, Moretti E, Avuzzi B, Giandini T, Munoz F, Magli A, Sanguineti G, Magdalena Waskiewicz J, Rago L, Cante D, Girelli G, Vavassori V, Di Muzio NG, Rancati T, Cozzarini C, Fiorino C. Pavarini M, et al. Among authors: girelli g. Radiother Oncol. 2024 Jun;195:110230. doi: 10.1016/j.radonc.2024.110230. Epub 2024 Mar 17. Radiother Oncol. 2024. PMID: 38503355
Relationships between bladder dose-volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer.
Carillo V, Cozzarini C, Rancati T, Avuzzi B, Botti A, Borca VC, Cattari G, Civardi F, Esposti CD, Franco P, Girelli G, Maggio A, Muraglia A, Palombarini M, Pierelli A, Pignoli E, Vavassori V, Zeverino M, Valdagni R, Fiorino C. Carillo V, et al. Among authors: girelli g. Radiother Oncol. 2014 Apr;111(1):100-5. doi: 10.1016/j.radonc.2014.02.006. Epub 2014 Mar 13. Radiother Oncol. 2014. PMID: 24631144
Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: Results of a cohort study.
Cozzarini C, Rancati T, Carillo V, Civardi F, Garibaldi E, Franco P, Avuzzi B, Esposti CD, Girelli G, Iotti C, Palorini F, Vavassori V, Valdagni R, Fiorino C. Cozzarini C, et al. Among authors: girelli g. Radiother Oncol. 2015 Aug;116(2):185-91. doi: 10.1016/j.radonc.2015.07.048. Epub 2015 Aug 11. Radiother Oncol. 2015. PMID: 26276529 Clinical Trial.
Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy.
Palorini F, Rancati T, Cozzarini C, Improta I, Carillo V, Avuzzi B, Casanova Borca V, Botti A, Degli Esposti C, Franco P, Garibaldi E, Girelli G, Iotti C, Maggio A, Palombarini M, Pierelli A, Pignoli E, Vavassori V, Valdagni R, Fiorino C. Palorini F, et al. Among authors: girelli g. Radiother Oncol. 2016 Jan;118(1):92-8. doi: 10.1016/j.radonc.2015.11.036. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777123 Clinical Trial.
Patient-reported urinary incontinence after radiotherapy for prostate cancer: Quantifying the dose-effect.
Cozzarini C, Rancati T, Palorini F, Avuzzi B, Garibaldi E, Balestrini D, Cante D, Munoz F, Franco P, Girelli G, Sini C, Vavassori V, Valdagni R, Fiorino C. Cozzarini C, et al. Among authors: girelli g. Radiother Oncol. 2017 Oct;125(1):101-106. doi: 10.1016/j.radonc.2017.07.029. Epub 2017 Aug 18. Radiother Oncol. 2017. PMID: 28826629 Clinical Trial.
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study.
Bresolin A, Faiella A, Garibaldi E, Munoz F, Cante D, Vavassori V, Waskiewicz JM, Girelli G, Avuzzi B, Villa E, Magli A, Noris Chiorda B, Gatti M, Ferella L, Maggio A, Landoni V, Aimonetto S, Sini C, Rancati T, Sanguineti G, Valdagni R, Di Muzio N, Fiorino C, Cozzarini C. Bresolin A, et al. Among authors: girelli g. Radiother Oncol. 2021 May;158:74-82. doi: 10.1016/j.radonc.2021.02.026. Epub 2021 Feb 25. Radiother Oncol. 2021. PMID: 33639190
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation.
Sanguineti G, Pavarini M, Munoz F, Magli A, Cante D, Garibaldi E, Gebbia A, Noris Chiorda B, Girelli G, Villa E, Faiella A, Magdalena Waskiewicz J, Avuzzi B, Pastorino A, Moretti E, Rago L, Statuto T, Gatti M, Rancati T, Valdagni R, Luigi Vavassori V, Gisella Di Muzio N, Fiorino C, Cozzarini C. Sanguineti G, et al. Among authors: girelli g. Radiother Oncol. 2024 Mar;192:110088. doi: 10.1016/j.radonc.2024.110088. Epub 2024 Jan 8. Radiother Oncol. 2024. PMID: 38199284
Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
Fiorino C, Fellin G, Rancati T, Vavassori V, Bianchi C, Borca VC, Girelli G, Mapelli M, Menegotti L, Nava S, Valdagni R. Fiorino C, et al. Among authors: girelli g. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1130-7. doi: 10.1016/j.ijrobp.2007.07.2354. Epub 2007 Sep 19. Int J Radiat Oncol Biol Phys. 2008. PMID: 17881142
161 results